quant
(8)
Ahmed Bukhamseen and the price of knowing
He left actuarial work to build Quant, then turned to a stubborn problem: how to give Saudi property decisions a firmer footing. His route runs from a job offer that became a client to a view of the market from space.
Sergey Savastiouk
Sergey Savastiouk, Ph.D., is the founder and CEO of Tickeron, a Reno-based platform that pairs artificial intelligence with plain-language explanation to give self-directed investors and advisors trading signals, pattern recognition, and automated 'AI robots.' A former applied-mathematics professor at Santa Clara University with two prior startups behind him, he turned the losses of the 2008 crisis into a mission to hand retail investors the kind of algorithmic tools once reserved for institutions.
Jonathan Wang
Jonathan Wang is the co-founder and CEO of Watershed (Watershed Informatics / Watershed Bio), a Cambridge-based biocomputing platform that lets biologists run complex multi-omics analyses without writing code. An MIT computer scientist who once built a high-frequency trading hedge fund out of his dorm room, Wang co-founded Domeyard before pivoting to biology in 2019, applying the speed-obsessed engineering culture of quant finance to the sprawling data problem of modern drug discovery. Watershed raised a $14.5M Series A led by Canvas Ventures in 2023 and aims to become the dominant biocomputing platform for the world's scientists.
Junchen Wu
Junchen (William) Wu, PhD, CFA, is the co-founder and CEO of Menos AI, a Silicon Valley fintech building agentic AI for hedge funds and asset managers. A former Head of Quant at Northern Trust and risk portfolio manager for a $3B multi-strategy book in Boston, he is shipping Sonαr, an institutional-grade AI idea-generation platform that turns market noise into structured trade ideas. Backed by a $5.2M oversubscribed seed round, he is on a mission to give buyside teams less noise and more signal.
Rohan Kodialam
Rohan Kodialam is the co-founder and CEO of Sphinx, a New York applied-AI research firm building agents that actually understand data. A former Citadel quant who learned to squeeze alpha out of messy alternative datasets, and an MIT-trained researcher who once taught transformers to read hierarchical data, he started Sphinx on a simple observation: software engineers got Copilot, everyone else got ChatGPT, and data scientists got nothing. In 2025 Sphinx launched out of stealth with a $9.5M seed led by Lightspeed and backers including Steve Cohen and Naveen Rao, betting that the next frontier of AI is not language or code, but the spreadsheets and warehouses where real decisions get made.
Aaron Wang
Aaron Wang is the co-founder and CEO of Alex (formerly Apriora), a San Francisco AI company whose autonomous recruiter, also named Alex, runs thousands of phone and video interviews a day for Fortune 100s, Big Four accounting firms, and staffing agencies. A Brown triple major who went from a quant trading desk and Facebook AI Research to a Y Combinator startup, Wang bet that a 10-minute conversation reveals more than any LinkedIn profile, then bought the alex.com domain for more than $500K to prove it. The company raised a $17M Series A led by Peak XV Partners in September 2025.
Vinesh Jha
Vinesh Jha is the founder and CEO of ExtractAlpha, an independent alternative-data research firm that turns messy datasets into tradable signals for hedge funds and institutional investors. A pure-mathematician-turned-quant, he cut his teeth ranking Wall Street analysts at StarMine, built systematic strategies at Merrill Lynch, Morgan Stanley, and PDT Partners, then went out on his own in 2013. After ExtractAlpha merged with the crowdsourced-estimates platform Estimize in 2021, he runs both, leading a team spread across Hong Kong, the US, Europe, and Canada with a near-religious insistence on rigorous, point-in-time testing over a good story.
Bob Elliott
Bob Elliott is the co-founder, CEO and CIO of Unlimited Funds, a New York firm that uses Bayesian machine learning to replicate the returns of hedge funds, venture capital and private equity inside low-cost ETFs. A Harvard-trained botanist turned macro investor, he spent roughly 15 years at Bridgewater Associates, where he sat on the Investment Committee, helped run the flagship Pure Alpha fund, and built and led Ray Dalio's personal research team for nearly a decade. Today he is one of the most-followed independent macro voices on financial Twitter and the manager behind the HFND and HFGM ETFs.